Medical Affairs Excellence Research
|Building Best-in-Class Capabilities for Medical Affairs |
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency... (ID POP-228) |
Companies Profiled: Abbott, Akron Molecules, Alkem Laboratories, Astellas, more ...
Price: $6250.00 Free Excerpt Available
|Medical Affairs Strategies to Deliver Value to Payer Groups |
In recent times, pharmaceutical companies have turned to their Medical Affairs function to establish meaningful relationships with payer groups, including Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), owing to their rising influence on market access... (ID POP-284) |
Companies Profiled: Abbott, Abbvie, Actelion, Astellas, more ...
Price: $5000.00 Free Excerpt Available
|Best Practices in Establishing Medical Affairs Capabilities in Emerging Countries: Using Structure, Staffing, and Responsibilities to Create an Effective Medical Affairs Group in TMEA |
With pharmaceutical companies facing diverse markets around the world, it is challenging to create and maintain an effective Medical Affairs group in less understood regions such as TMEA, which includes Turkey, Middle East, and South Africa... (ID POP-289) |
Companies Profiled: Abbvie, AstraZeneca, Celgene, Gilead Sciences, more ...
Price: $3700.00 Free Excerpt Available